-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q2 2024.
- Vir Biotechnology, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$1.51M, a 46.9% increase year-over-year.
- Vir Biotechnology, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$9.23M, a 102% decline year-over-year.
- Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2023 was -$13.1M, a 105% decline from 2022.
- Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2022 was $238M, a 1024% increase from 2021.
- Vir Biotechnology, Inc. annual Income Tax Expense (Benefit) for 2021 was $21.2M, a 39193% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)